Selenium and cancer: a review

Bioinorganic Chemistry
|January 1, 1976
PubMed

Insights

Selenium supplementation, even in subtoxic amounts, significantly reduces spontaneous mammary tumors in mice. However, arsenic, a selenium antagonist, while lowering tumor incidence, accelerates tumor growth in affected animals.

Area of Science:

  • Nutritional Biochemistry
  • Oncology
  • Toxicology

Background:

  • Selenium is an essential trace element known to inhibit chemically induced tumors in animal models.
  • Previous research indicates a potential role for selenium in cancer prevention.

Purpose of the Study:

  • To investigate the effect of subtoxic selenium (selenite) on spontaneous mammary tumor incidence in female C3H mice.
  • To evaluate the impact of arsenic (arsenite), a selenium antagonist, on tumor incidence and growth rates.

Main Methods:

  • Administration of subtoxic amounts of selenite in drinking water to female C3H mice.
  • Administration of arsenite in drinking water at 10 ppm to assess its effects.
  • Monitoring tumor incidence, growth rates, animal health, and lifespan.

Main Results:

  • Selenite supplementation significantly lowered the incidence of spontaneous mammary tumors without adverse effects on health or lifespan.
  • Arsenite administration also reduced tumor incidence but dramatically accelerated tumor growth in mice that developed tumors.
  • Epidemiological data suggest lower human cancer mortality in regions with adequate dietary selenium intake.

Conclusions:

  • Subtoxic selenium intake can be a protective factor against spontaneous mammary tumorigenesis.
  • Arsenic's antagonistic effect on selenium highlights complex interactions influencing cancer progression.
  • Dietary selenium levels may correlate with reduced human cancer mortality, warranting further investigation.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...